Copyright
©The Author(s) 2021.
World J Gastroenterol. Aug 28, 2021; 27(32): 5404-5423
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5404
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5404
Figure 2 Recombinant human angiopoietin-like protein 4 improved ischemia-reperfusion-induced intestinal histopathologically and serum lactate dehydrogenase.
A and B: Pathologic changes of intestine (scale bar = 100 μm) of (A) tissue and (B) serum lactate dehydrogenase (LDH) in different groups (mean ± SD, n = 8). bP < 0.01 vs sham; dP < 0.01 vs ischemia-reperfusion. I/R: Ischemia-reperfusion.
- Citation: Wang ZY, Lin JY, Feng YR, Liu DS, Zhao XZ, Li T, Li SY, Sun JC, Li SF, Jia WY, Jing HR. Recombinant angiopoietin-like protein 4 attenuates intestinal barrier structure and function injury after ischemia/reperfusion. World J Gastroenterol 2021; 27(32): 5404-5423
- URL: https://www.wjgnet.com/1007-9327/full/v27/i32/5404.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i32.5404